PRLD PRELUDE THERAPEUTICS
Permanent stock page ↗Health Care · Russell 2000
Next earnings: Wed 11 Nov 2026 · estimated
What 9 analyst firms say about PRELUDE THERAPEUTICS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
7 rated views · 9 analyst/firm records · 9 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Fewer than 4 price targets in the last 6 months (2)
- Russell 2000 · Safest consensus · 6MNot scored · Fewer than 4 price targets in the last 6 months (2)
Recent analyst activity · last 90 days
Our tracked history has 3 reports on PRLD from 3 analyst firms in the last 90 days (9 firms in the past year).
Comparing each firm's latest target with its previous one: 1 has its first observed target in the past year.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Citigroup | Unnamed analyst | Buy | 14 Oct 2026 | — |
| Citizens JMP | Reni Benjamin | Buy | 11 Mar 2026 | 6.00 USD |
| D Boral Capital | Jason Kolbert | Buy | 4 May 2026 | 9.00 USD |
| Goldman Sachs | Unnamed analyst | — | 15 May 2026 | — |
| H.C. Wainwright | Robert Burns | Buy | 29 Jul 2026 | 8.00 USD |
| Jefferies | Roger Song | Buy | 12 Mar 2026 | 10.00 USD |
| JPMorgan | Joyce Zhou | Buy | 17 Sep 2026 | 12.00 USD |
| Weiss Ratings | Unnamed analyst | — | 27 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 28 Apr 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 07:39 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.